<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Tests of respiratory muscle strength
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Tests of respiratory muscle strength
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Tests of respiratory muscle strength
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gerrard Rafferty, PhD, SFHEA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Noah Lechtzin, MD, MHS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Meredith C McCormack, MD, MHS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 27, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many chronic respiratory diseases and neuromuscular disorders are associated with respiratory muscle weakness  (
         <a class="graphic graphic_table graphicRef69167" href="/z/d/graphic/69167.html" rel="external">
          table 1
         </a>
         ). Respiratory muscle strength can be assessed using several methods, most of which are noninvasive, although a small proportion of patients require additional invasive testing.
        </p>
        <p>
         Measurement and interpretation of the three major tests of respiratory muscle strength, maximal inspiratory pressure (PImax), maximal expiratory pressure (PEmax), and sniff nasal inspiratory pressure (SNIP) are discussed in this topic review. Assessments of other aspects of pulmonary function (eg, airflow, lung volumes, gas exchange) and evaluation of patients with suspected respiratory muscle weakness are described separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6971.html" rel="external">
          "Selecting reference values for pulmonary function tests"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6971.html" rel="external">
          "Selecting reference values for pulmonary function tests"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1465.html" rel="external">
          "Flow-volume loops"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         When performing tests of respiratory muscle strength, we adhere to the standards set out by the American Thoracic Society and the European Respiratory Society [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3305648997">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Common indications for measurement of respiratory muscle strength include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with suspected respiratory muscle weakness (eg, patient with known neuromuscular disease with a weak cough, unexplained dyspnea or dyspnea on exertion, and/or orthopnea). (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Respiratory muscle strength testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5115.html" rel="external">
          "Diagnostic evaluation of adults with bilateral diaphragm paralysis", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16185.html" rel="external">
          "Diagnosis and management of nontraumatic unilateral diaphragmatic paralysis (complete or partial) in adults", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with lung function tests that show reduced vital capacity (VC). (See
         <a class="medical medical_review" href="/z/d/html/1436.html" rel="external">
          "Approach to the patient with dyspnea", section on 'Pulmonary function tests'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Pulmonary function testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with known respiratory muscle weakness to monitor improvement, stability, or deterioration. (See
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Treatment of the underlying disorder'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Physiologic evidence of respiratory muscle weakness'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MAXIMAL INSPIRATORY AND EXPIRATORY PRESSURE
         </span>
        </p>
        <p class="headingAnchor" id="H982892222">
         <span class="h2">
          Devices and attachments
         </span>
         <span class="headingEndMark">
          —
         </span>
         Measurement of the maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax) can be performed using devices that are widely available, some of which are self-contained handheld devices  (
         <a class="graphic graphic_figure graphicRef81704" href="/z/d/graphic/81704.html" rel="external">
          figure 1
         </a>
         ) and others that are connected to a computer for data acquisition [
         <a href="#rid3">
          3-5
         </a>
         ]. Devices can be simple manually operated devices with a separate pressure transducer, or automated electronic devices integrating all components.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Side port
         </strong>
         ─ The device should contain a side port that allows a small air leak to prevent the patient from generating pressure by using their cheek muscles (eg, a hole in the device that is 2 mm wide and 20 to 30 mm long) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient-device interface
         </strong>
         ─ The patient-device interface can be any of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Flanged mouthpiece ─ A sterile rubber flanged mouthpiece, which can be sterilized between patients, is commonly used due to its ease of use by patients and the ability to form a leak-free seal  (
         <a class="graphic graphic_figure graphicRef81704" href="/z/d/graphic/81704.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A facemask seal ─ A facemask seal, similar to that used for noninvasive ventilation, can be used for individuals who cannot obtain a tight seal with the lips  (
         <a class="graphic graphic_picture graphicRef127773" href="/z/d/graphic/127773.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A tube interface ─ Large-diameter stiff rubber tubing can be used for patients capable of generating large pressures who rupture the seal with the lips at the mouthpiece during testing, especially during the PEmax maneuver  (
         <a class="graphic graphic_picture graphicRef134501" href="/z/d/graphic/134501.html" rel="external">
          picture 2
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transducer
         </strong>
         ─ The pressure generated against an occlusion during inspiration or expiration (ie, the PImax and PEmax, respectively) is measured using a suitable pressure transducer (ideally electronic transducer) that is part of the device or connected to the device via a narrow-gauge catheter. The output from the transducer is displayed on the device itself or on a computer. Units of pressure are measured in centimeters of water (cm H
         <sub>
          2
         </sub>
         O).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H634373723">
         <span class="h2">
          Technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         The technique required for testing PImax and PEmax measures the pressure generated against an occluded airway during maximal inspiration or expiration, respectively. During all maneuvers, patient cooperation and effort should be noted and recorded. Obtaining a tight seal with the lips is important. (See
         <a class="local">
          'Poor patient effort, technique, and repeatability'
         </a>
         below and
         <a class="local">
          'Poor patient-device interface'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h3">
          Maximal inspiratory pressure (PImax)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The maximal inspiratory pressure (PImax, sometimes also known as MIP) reflects the strength of the diaphragm and other inspiratory muscles (eg, rib cage, sternocleidomastoid). (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Muscles of respiration and cough'
         </a>
         .)
        </p>
        <p>
         To achieve a maximum value, it is important to explain and demonstrate the maneuver to the patient before and during the procedure. The patient should be seated and wearing a nose clip (unless an oronasal mask is used).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We instruct the patient to take a few tidal breaths through the mouthpiece or mask and then exhale slowly and completely (ie, to residual volume). We next instruct the patient to breathe in as hard as possible. The patient should maintain the inspiratory effort for at least 1.5 seconds. The largest
         <strong>
          negative
         </strong>
         pressure sustained for at least one second (not a transient spike) should be recorded  (
         <a class="graphic graphic_figure graphicRef134504" href="/z/d/graphic/134504.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We allow the patient to rest for approximately one minute and repeat the maneuver five times providing verbal or visual feedback after each maneuver. Sometimes additional maneuvers are required (eg, if the last measurement was the highest for the test session or if the second highest measurement is not at least 90 percent of the highest measurement). The goal is for the variability among maximum value measurements to be less than 10 cm H
         <sub>
          2
         </sub>
         O [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Poor patient effort, technique, and repeatability'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We report the maximum value achieved across all efforts (not a mean value) [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Interpretation (PImax, PEmax, SNIP)'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Maximal expiratory pressure (PEmax)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The maximal expiratory pressure (PEmax, also known as MEP) reflects the strength of the abdominal muscles and other expiratory muscles. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Muscles of respiration and cough'
         </a>
         .)
        </p>
        <p>
         We explain and demonstrate the maneuver to the patient before and during the procedure. The patient is seated and wearing a nose clip (unless a facemask is used).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We instruct the patient to take a few tidal breaths through the mouthpiece or mask. We next instruct the patient to take a maximal inspiration through the mouthpiece or mask (ie, to total lung capacity) and then blow out as hard as possible, similar to inflating a very stiff balloon. The patient should maintain expiratory effort for at least 1.5 seconds and the largest
         <strong>
          positive
         </strong>
         pressure sustained for at least one second (not a transient spike) should be recorded  (
         <a class="graphic graphic_figure graphicRef134504" href="/z/d/graphic/134504.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We allow the patient to rest for about one minute and then repeat the maneuver five times, providing verbal or visual feedback after each maneuver. Sometimes additional maneuvers are required. The goal is for the variability among maximum value measurements to be less than 10 cm H
         <sub>
          2
         </sub>
         O [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Poor patient effort, technique, and repeatability'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We report the maximum value achieved across all efforts (not a mean value). (See
         <a class="local">
          'Interpretation (PImax, PEmax, SNIP)'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H83782348">
         <span class="h1">
          SNIFF NASAL INSPIRATORY PRESSURE (SNIP)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The maximal sniff nasal inspiratory pressure (also called the sniff nasal force [SNIF]) is an indicator of inspiratory muscle strength. Because a mouthpiece is not used, SNIP is particularly helpful for patients with facial weakness who cannot obtain a tight seal around the mouthpiece for the maximal inspiratory pressure (PImax) test [
         <a href="#rid1">
          1
         </a>
         ]. For similar reasons, SNIP is also useful for children (over 5 years of age) [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p>
         However, SNIP is less reliable in individuals (adults and children) with occluded nostrils or upper airway obstruction (eg, nasal polyps or edema) since an adequate sniff maneuver can only be achieved if the contralateral nostril is not obstructed and allows the free passage of air. SNIP is also not suitable for patients with hyperinflation due to obstructive airways disease due to reduced transmission of pressure from the chest to the nose [
         <a href="#rid1">
          1,10-12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2673442255">
         <span class="h2">
          Device
         </span>
         <span class="headingEndMark">
          —
         </span>
         Measuring SNIP involves a nasal bung, which is inserted into one nostril. The bung is connected by a catheter to a suitable pressure transducer  (
         <a class="graphic graphic_figure graphicRef81704" href="/z/d/graphic/81704.html" rel="external">
          figure 1
         </a>
         ) that is connected to a readout system.
        </p>
        <p>
         Different sized sniff bungs are available commercially, although suitable devices can be constructed using fine bore tubing and rubber bungs or dental impression putty.
        </p>
        <p class="headingAnchor" id="H3703950088">
         <span class="h2">
          Technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         SNIP measures the pressure generated by maximal inhalation through one patent nostril. The sniff maneuver involves a coordinated contraction of the diaphragm and other inspiratory muscles which generally produces pressures in excess of those obtained during a maximal inspiratory pressure (PImax) maneuver [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Muscles of respiration and cough'
         </a>
         .)
        </p>
        <p>
         The sniff nasal inspiratory pressure test is performed using the following technique:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We insert a bung attached to the pressure transducer into one nostril (completely obstructing flow through that nostril).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We instruct the patient to sniff as strongly as possible through the contralateral unobstructed nostril.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We record the peak negative pressure (in the obstructed nostril).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We allow the patient to rest for one minute and repeat the sniff maneuver until a maximal peak
         <strong>
          negative
         </strong>
         pressure is obtained (less than 10 cm H
         <sub>
          2
         </sub>
         O variation); this may require up to 10 efforts [
         <a href="#rid10">
          10
         </a>
         ]. Since the test involves a simple natural maneuver it is relatively easy for patients to achieve maximal efforts with a little practice. Thus, less coaching is generally needed in between repeated attempts when compared with the PImax maneuver.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We report the maximum value across all efforts (not a mean value). Patient cooperation and effort should be noted. (See
         <a class="local">
          'Interpretation (PImax, PEmax, SNIP)'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1554887814">
         <span class="h1">
          ADDRESSING SOURCES OF ERROR
         </span>
         <span class="headingEndMark">
          —
         </span>
         The validity of maximal inspiratory pressure (PImax), sniff nasal inspiratory pressure (SNIP), and maximal expiratory pressure (PEmax) are directly related to the quality of the test from which they were measured. In patients with low-normal or low values, potential sources of error that should be considered include patient effort and technique, the patient-device interface, and equipment issues.
        </p>
        <p class="headingAnchor" id="H3190782741">
         <span class="h2">
          Poor patient effort, technique, and repeatability
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient effort and technique are probably the most common causes of error for low PImax and PEmax. As both tests require volitional effort, we report the degree of patient cooperation and effort alongside the test results.
        </p>
        <p>
         We suggest the following to minimize the impact of poor effort and technique:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Experienced technician - Since measurements of respiratory muscle strength are often unfamiliar maneuvers, only an experienced technologist should supervise testing. Such an individual should provide careful instructions as to the test procedure and provide encouragement and motivation along with feedback on test performance.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grading effort and repeatability among multiple efforts - We grade the quality of each test according to patient effort and repeatability  (
         <a class="graphic graphic_table graphicRef72052" href="/z/d/graphic/72052.html" rel="external">
          table 2
         </a>
         ). In this system, excellent effort and repeatability (&lt;5 cm H
         <sub>
          2
         </sub>
         O difference among measurements) receive the highest quality grade, while poor effort or poor repeatability (&gt;20 cm H
         <sub>
          2
         </sub>
         O difference among measurements) receives the lowest grade. In general, 80 to 90 percent of healthy adults achieve less than 10 cm H
         <sub>
          2
         </sub>
         O difference among measurements [
         <a href="#rid14">
          14,15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Many clinical laboratories perform only five maneuvers for the PImax and PEmax each. However, in our experience, the best values during a test session are sometimes obtained after more than five efforts (eg, up to 15) [
         <a href="#rid7">
          7,16
         </a>
         ]. In addition, it is prudent that up to three additional maneuvers be performed if the last measurement was the highest for the test session, or if the second highest measurement is not at least 90 percent of the highest measurement.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3848033077">
         <span class="h2">
          Poor patient-device interface
         </span>
         <span class="headingEndMark">
          —
         </span>
         Error can be due to an inadequate patient-device interface.
        </p>
        <p>
         For PImax and PEmax maneuvers, the patient needs to form a tight seal with their lips around the mouthpiece of the device (the SNIP maneuver is less affected by the patient-device interface since a seal with the lips is not needed). However, some patients with orofacial muscle weakness are
         <strong>
          not
         </strong>
         able to obtain a good seal with the lips. For such patients, we suggest the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The patient may be able to use their hands to press their lips around the mouthpiece during each maneuver [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alternatively, the technologist or physician can press the patient's lips against the mouthpiece to obtain a good seal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A facemask interface  (
         <a class="graphic graphic_picture graphicRef127773" href="/z/d/graphic/127773.html" rel="external">
          picture 1
         </a>
         ) or a tube interface (ie, a wide diameter rubber tube pressed firmly against the face around the lips  (
         <a class="graphic graphic_picture graphicRef134501" href="/z/d/graphic/134501.html" rel="external">
          picture 2
         </a>
         )) can be substituted for the mouthpiece. (See
         <a class="local">
          'Devices and attachments'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The sniff nasal inspiratory pressure can be used instead of the PImax. (See
         <a class="local">
          'Devices and attachments'
         </a>
         above and
         <a class="local">
          'Sniff nasal inspiratory pressure (SNIP)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         For patients who
         <strong>
          break
         </strong>
         the seal of a standard mouthpiece or facemask due to high pressures during the maneuver (more commonly seen in patients without respiratory muscle weakness), a tube interface can be used. The latter is based on several small observational studies which demonstrated that patients
         <strong>
          without
         </strong>
         respiratory muscle weakness frequently broke their seal (particularly during expiratory efforts) with a standard mouthpiece or facemask, but not a tube interface [
         <a href="#rid18">
          18,19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H459309690">
         <span class="h2">
          Equipment error
         </span>
         <span class="headingEndMark">
          —
         </span>
         We adhere to guidelines describing the appropriate characteristics for equipment required to measure respiratory muscle function [
         <a href="#rid1">
          1,2
         </a>
         ]. Potential sources of error include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type of pressure gauge and display
         </strong>
         ─ Electronic devices with either a self-contained digital display or computer connection are preferable. A display of the pressure waveform produced during the maneuver is also helpful as visual inspection can help with quality control and ensure correct performance of the maneuver  (
         <a class="graphic graphic_picture graphicRef134502" href="/z/d/graphic/134502.html" rel="external">
          picture 3
         </a>
         ). This can be of particular relevance for SNIP when a short, sharp effort is required.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Our rationale for electronic devices is that the dial on mechanical devices can be difficult to read accurately, particularly if there are marked fluctuations in generated pressure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transducer performance
         </strong>
         ─ A sensitive transducer with a resolution of at least 0.5 cm H
         <sub>
          2
         </sub>
         O, a range 300 cm H
         <sub>
          2
         </sub>
         O, and a flat frequency response up to 15 Hz is required. Validation of equipment performance characteristics should be performed with the appropriate tubing and any additional fittings connected as these can significantly affect transducer performance. This is particularly important for SNIP measurement since rapid pressure changes occur during the maneuver.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sampling frequency
         </strong>
         ─ For noncommercial systems that are assembled “in house” by the pulmonary function laboratory, the pressure should be recorded using a sample frequency of at least 100 Hz. Most commercially available devices have this feature built into them, eliminating operating characteristics as a source of error.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Calibration
         </strong>
         ─ Regular verification of system accuracy should be performed by comparison with a manometer [
         <a href="#rid20">
          20
         </a>
         ]. Systems should be calibrated before use and at regular intervals depending on how frequently tests are performed (eg, monthly if tests are performed more than once a month).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          INTERPRETATION (PIMAX, PEMAX, SNIP)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interpreting tests of respiratory muscle strength requires knowledge of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal reference ranges. (See
         <a class="local">
          'Data interpretation (comparison with the reference range)'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The clinical context (eg, diagnostic, prognostic). (See
         <a class="local">
          'Clinical interpretation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3128575681">
         <span class="h2">
          Data interpretation (comparison with the reference range)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maximal inspiratory pressure (PImax), sniff nasal inspiratory pressure (SNIP), and maximal expiratory pressure (PEmax) are interpreted by comparing values to a reference range derived from patients with normal respiratory muscle strength. However, reference ranges are poorly defined and are wide-ranging, leading to inaccuracy, especially when the result falls within the lower limit of normal or just below normal.
        </p>
        <p>
         Reference ranges for PImax, PEmax and SNIP have been published according to sex and age, since values decline with age and are lower in women than in men  (
         <a class="graphic graphic_table graphicRef102592" href="/z/d/graphic/102592.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef134503" href="/z/d/graphic/134503.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid6">
          6,21
         </a>
         ]. Reference ranges for SNIP are also available for children [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         When interpreting data from tests of respiratory muscle strength we suggest the following approach:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mid- to high-normal range or above the upper limit of normal
         </strong>
         ─ Values that lie in the mid- to high-normal range or above the upper limit of normal reliably exclude clinically significant respiratory muscle weakness (ie, good negative predictive value).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lower quarter of the normal range or below the lower limit of normal
         </strong>
         ─ Values that lie within the lower quarter of the normal range or below the lower limit of normal (LLN) may reflect respiratory muscle weakness but may also reflect other conditions (ie, poor positive predictive value) [
         <a href="#rid22">
          22,23
         </a>
         ]. This includes the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Poor effort ─ Poor effort is one of the most common reasons for low values and is generally commented upon by the technician. (See
         <a class="local">
          'Poor patient effort, technique, and repeatability'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Technical factors ─ Technical factors can also contribute to low values. These include suboptimal technician coaching, poor patient-device interface, and equipment errors, which are discussed above. (See
         <a class="local">
          'Addressing sources of error'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lung hyperinflation ─ Patients with lung hyperinflation due to severe airway obstruction may generate a low PImax despite normal inspiratory muscle strength [
         <a href="#rid24">
          24-27
         </a>
         ]. This is due to shortening of diaphragmatic muscle fibers and the mechanical disadvantage conferred by lung hyperinflation [
         <a href="#rid28">
          28
         </a>
         ]. In such patients expectations of PImax should be adjusted downward as lung hyperinflation increases  (
         <a class="graphic graphic_figure graphicRef70968" href="/z/d/graphic/70968.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         General factors ─ General factors such as older age, weak handgrip strength, malnutrition, poor health, low physical activity, and short stature have all been associated with low values [
         <a href="#rid5">
          5,14,15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Thus, low values do not reliably confirm respiratory muscle weakness and the diagnosis should be supplemented with other findings, repeat testing, and/or invasive testing. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Diagnosis'
         </a>
         and
         <a class="local">
          'Additional tests (invasive)'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2089336006">
         <span class="h2">
          Clinical interpretation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Respiratory muscle strength testing plays a key role in the diagnosis, prognosis, and follow-up of patients with respiratory muscle weakness.
        </p>
        <p class="headingAnchor" id="H325410426">
         <span class="h3">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with suspected respiratory muscle weakness, the PImax, PEmax, and SNIP are considered in conjunction with other measures, most commonly supine and upright vital capacity (VC) or forced vital capacity (FVC) for the diagnosis (or exclusion) of respiratory muscle weakness. Inconclusive studies may prompt additional investigations [
         <a href="#rid29">
          29
         </a>
         ]. Further details regarding criteria for the diagnosis of respiratory muscle weakness are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Diagnostic evaluation'
         </a>
         and
         <a class="local">
          'Additional tests (invasive)'
         </a>
         below.)
        </p>
        <p>
         The sensitivity and specificity of respiratory muscle strength tests have been compared with the VC for the diagnosis of respiratory muscle weakness:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The PImax is more specific for respiratory muscle weakness than a fall in VC on supination [
         <a href="#rid30">
          30,31
         </a>
         ], although the latter may be more specific for the detection of diaphragmatic weakness than the PImax [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The VC falls late in progressive neuromuscular disease (eg, amyotrophic lateral sclerosis [ALS]) while the PImax falls earlier and correlates better with disease progression [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="local">
          'Clinical course and criteria for detecting change'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both the PImax and VC have similar sensitivity (55 versus 53 percent) and specificity (83 versus 89 percent) for detecting hypercapnic respiratory failure [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Diagnostic accuracy for inspiratory muscle weakness is improved when PImax and SNIP are
         <strong>
          both
         </strong>
         measured. Although SNIP and PImax are both used to assess inspiratory muscle strength, the agreement between the results of these testing modalities is variable and hence these two tests should be regarded as complementary rather than interchangeable. In a study of 182 patients referred to a specialist laboratory for assessment of possible respiratory muscle weakness, 40 percent were diagnosed as weak by PImax, 42 percent by SNIP, and 32 percent by PImax plus SNIP but the combination of PImax and SNIP reduced the diagnosis of weakness by 19 percent compared to either test alone [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         PImax, SNIP, and PEmax may help classify respiratory muscle weakness as primarily affecting the inspiratory muscles or expiratory muscles. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A low PImax and SNIP but a normal PEmax suggests isolated inspiratory muscle weakness (usually diaphragmatic).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A low PImax, SNIP, and PEmax suggests generalized skeletal muscle weakness (eg, ALS).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A normal PImax and SNIP and low PEmax suggests isolated expiratory muscle weakness, although this is rare.
        </p>
        <p>
        </p>
        <p>
         However, from a practical standpoint, this differentiation may not be helpful in determining the underlying
         <strong>
          cause
         </strong>
         of respiratory muscle weakness (eg, ALS versus myotonic dystrophy) since many neuromuscular disorders may have mixed involvement of respiratory and skeletal muscle weakness.
        </p>
        <p class="headingAnchor" id="H2017572969">
         <span class="h3">
          Severity and prognosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The PImax, SNIP, and PEmax can be used to quantify the severity of respiratory muscle weakness and predict its clinical consequences. This is illustrated by the following observations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A PImax below one-third of normal predicts hypercapnic respiratory failure (PaCO
         <sub>
          2
         </sub>
         &gt;45 mmHg) [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A SNIP that is 35 percent of normal predicts likely ventilatory failure in patients with ALS  (
         <a class="graphic graphic_figure graphicRef103381" href="/z/d/graphic/103381.html" rel="external">
          figure 4
         </a>
         ) [
         <a href="#rid11">
          11,35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A PEmax less than 60 cm H
         <sub>
          2
         </sub>
         O predicts a weak cough with difficulty clearing secretions [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A reduced PImax is associated with increased mortality [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The PImax, SNIP, or PEmax usually decline before the symptoms or signs of respiratory muscle weakness emerge. This is due to the large reserve of respiratory muscle strength that normally exists, such that considerable muscle strength must be lost before symptoms or signs develop [
         <a href="#rid39">
          39
         </a>
         ]. This is particularly true for sedentary patients without heart or lung disease. Such patients place minimal demand on their respiratory muscles and may not become symptomatic until they have severe respiratory muscle weakness [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         The most powerful biomarker for mortality stratification for ALS is diaphragmatic strength as measured by phrenic nerve stimulation, but the predictive power of SNIP is also excellent, whereas VC shows little or no decline until 12 months before death or ventilation [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Chronic ventilatory support'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">
          "Symptom-based management of amyotrophic lateral sclerosis", section on 'Respiratory function management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1543090477">
         <span class="h3">
          Clinical course and criteria for detecting change
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serial measurements of the PImax, SNIP, and PEmax can be used to evaluate whether the respiratory muscle weakness has improved, remained stable, or worsened. This is particularly helpful for evaluating the response to therapy (eg, immunosuppressive therapy for myasthenia gravis or Guillain-Barré syndrome) and for planning an intervention in a progressive neuromuscular disease (eg, noninvasive or mechanical ventilation). (See
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Chronic ventilatory support'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">
          "Symptom-based management of amyotrophic lateral sclerosis", section on 'Respiratory function management'
         </a>
         .)
        </p>
        <p>
         Detecting a "significant" physiologic change must be distinguished from normal test variation. We use a change of more than 25 cm H
         <sub>
          2
         </sub>
         O as the threshold to identify change of respiratory muscle strength that does not lie within a normal variance. The rationale for this criterion is based upon studies in healthy individuals, which demonstrate that 95 percent of normal test-to-test variation is less than 25 cm H
         <sub>
          2
         </sub>
         O [
         <a href="#rid41">
          41,42
         </a>
         ]. However, it is ideal that each laboratory perform their own internal study using patients with neuromuscular disease to confirm this cutoff as appropriate in the population served. In addition, it is important to bear in mind that a “significant” physiologic change may or may not correlate with a clinically meaningful change in the patient’s respiratory symptoms [
         <a href="#rid43">
          43-45
         </a>
         ].
        </p>
        <p>
         Threshold values that may prompt mechanical ventilation are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Chronic ventilatory support'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">
          "Symptom-based management of amyotrophic lateral sclerosis", section on 'Respiratory function management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          ADDITIONAL TESTS (INVASIVE)
         </span>
         <span class="headingEndMark">
          —
         </span>
         In most patients, the maximal inspiratory pressure (PImax), maximal expiratory pressure (PEmax) and sniff nasal inspiratory pressure (SNIP) are sufficient to make a diagnosis of respiratory muscle weakness when taken together with other clinical features. However, when the diagnosis of respiratory muscle weakness is in doubt, more invasive testing can be performed, depending on availability and need. These complex measurements are best made in specialized centers by a pulmonologist and/or neurologist.
        </p>
        <p>
         Invasive testing includes the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sniff esophageal pressure
         </strong>
         ─ Sniff esophageal pressure is measured using a pressure catheter in the lower esophagus. Similar to SNIP, it uses the sniff maneuver to measure inspiratory muscle strength and is therefore suitable for patients with poor seal around the mouthpiece. However, unlike SNIP, sniff esophageal pressure is less likely to be inaccurate in patients with hyperinflation since there are no issues with the transmission of pressure from the thorax to the esophagus (sniff esophageal pressure) as opposed to transmission of pressure from the thorax to the nose (SNIP) [
         <a href="#rid1">
          1,10-12,46
         </a>
         ]. (See
         <a class="local">
          'Sniff nasal inspiratory pressure (SNIP)'
         </a>
         above and
         <a class="local">
          'Addressing sources of error'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastric pressure
         </strong>
         ─ Gastric pressure, measured with a pressure catheter in the stomach following maximal cough efforts, reflects volitional expiratory (particularly abdominal) muscle strength [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Nonvolitional abdominal (expiratory) muscle strength can also be measured by recording gastric pressure following surface magnetic stimulation posteriorly in the mid-line at the level of T10 [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Assessing cough strength is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Assessing cough strength'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tests of diaphragm strength
         </strong>
         ─ Several tests can be used to test diaphragm strength. These tests are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Diaphragmatic function'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5115.html" rel="external">
          "Diagnostic evaluation of adults with bilateral diaphragm paralysis", section on 'Specific diaphragmatic tests'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16185.html" rel="external">
          "Diagnosis and management of nontraumatic unilateral diaphragmatic paralysis (complete or partial) in adults", section on 'Sniff test'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3803169981">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118218.html" rel="external">
          "Society guideline links: Pulmonary function testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         ─ The three most common noninvasive tests that measure respiratory muscle strength include the following (see
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Indications'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maximal inspiratory pressure (PImax)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maximal expiratory pressure (PEmax)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sniff nasal inspiratory pressure (SNIP)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The PImax and SNIP reflect the strength of the diaphragm and other inspiratory muscles, while the PEmax reflects the strength of the abdominal and other expiratory muscles. (See
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Muscles of respiration and cough'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Common indications for their measurement include clinically suspected respiratory muscle weakness, lung function tests consistent with respiratory muscle weakness (eg, restrictive pattern, low vital capacity), and evaluation of whether respiratory muscle weakness has improved, remained stable, or worsened.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Testing technique
         </strong>
         ─ The technique required for testing PImax and PEmax involves measuring the pressure generated against an occluded airway during maximal inspiration or expiration, respectively  (
         <a class="graphic graphic_figure graphicRef81704" href="/z/d/graphic/81704.html" rel="external">
          figure 1
         </a>
         ). These tests are effort-dependent and obtaining a tight seal at the lips on the flanged mouthpiece is important for success. Several efforts are made with coaching and feedback provided in between each maneuver. (See
         <a class="local">
          'Maximal inspiratory and expiratory pressure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The technique for SNIP involves measuring the pressure generated by maximal inhalation through one patent nostril. The sniff maneuver is a little easier than PImax or PEmax maneuver and is more suitable for patients who cannot obtain a tight seal with their lips on the mouthpiece. It is not suitable for patients who have upper airway obstruction (eg, nasal polyps) or hyperinflation from obstructive lung disease. (See
         <a class="local">
          'Maximal inspiratory and expiratory pressure'
         </a>
         above and
         <a class="local">
          'Sniff nasal inspiratory pressure (SNIP)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interpretation
         </strong>
         ─ Test results are compared with normal reference ranges  (
         <a class="graphic graphic_table graphicRef102592" href="/z/d/graphic/102592.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef134503" href="/z/d/graphic/134503.html" rel="external">
          table 4
         </a>
         ) and should take into consideration potential errors associated with testing and the clinical context (eg, diagnostic, prognostic). (See
         <a class="local">
          'Data interpretation (comparison with the reference range)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mid- to high-normal
         </strong>
         ─ Patients with values for PImax, SNIP, and/or PEmax that lie in the mid- to high-normal range or above the upper limit of normal generally do not have respiratory muscle weakness (ie, good negative predictive value).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Low or low-normal
         </strong>
         ─ Test results that lie within the lower quarter of the normal range or below the lower limit of normal (LLN) may reflect respiratory muscle weakness but may also reflect poor effort or difficulty with performing the maneuvers (ie, poor positive predictive value). Other factors that can contribute to low values include lung hyperinflation, older age, weak handgrip strength, malnutrition, poor health, low physical activity, short stature, suboptimal technician coaching, poor patient-device interface, and technical errors. (See
         <a class="local">
          'Addressing sources of error'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Respiratory muscle strength testing plays a key role in the diagnosis of respiratory muscle weakness, determination of its severity, prediction of its clinical sequelae, evaluation of its clinical course, and need for intervention. Further details regarding criteria for the diagnosis and management of respiratory muscle weakness are provided separately. (See
         <a class="local">
          'Clinical interpretation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Diagnostic evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5124.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Management", section on 'Chronic ventilatory support'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional tests
         </strong>
         ─ In most patients PImax, PEmax and SNIP are sufficient to make a diagnosis of respiratory muscle weakness when taken together with other clinical features and pulmonary function testing. When the diagnosis of respiratory muscle weakness is in doubt, additional (typically invasive) testing can be performed, depending on availability and need.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These include the sniff esophageal pressure (measures inspiratory pressure), gastric pressure (measures expiratory pressure), and tests of diaphragmatic strength. These tests generally require the insertion of a pressure-measuring catheter. Test of diaphragmatic strength are described separately. (See
         <a class="local">
          'Additional tests (invasive)'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5121.html" rel="external">
          "Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation", section on 'Diaphragmatic function'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5115.html" rel="external">
          "Diagnostic evaluation of adults with bilateral diaphragm paralysis", section on 'Measurement of transdiaphragmatic pressure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5115.html" rel="external">
          "Diagnostic evaluation of adults with bilateral diaphragm paralysis", section on 'Imaging studies'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5115.html" rel="external">
          "Diagnostic evaluation of adults with bilateral diaphragm paralysis", section on 'Diaphragmatic electromyography'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9264311">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Paul L Enright, MD and John Moxham, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laveneziana P, Albuquerque A, Aliverti A, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J 2019; 53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamnegård CH, Wragg S, Kyroussis D, et al. Portable measurement of maximum mouth pressures. Eur Respir J 1994; 7:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson, L. A method for measuring sniff nasal inspiratory pressure using the PK Morgan Pm meter. Inspire, the Official J Assoc Respir Technicians Physiologists 1997; 1:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL, Kronmal RA, Manolio TA, et al. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med 1994; 149:430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009; 54:1348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wen AS, Woo MS, Keens TG. How many maneuvers are required to measure maximal inspiratory pressure accurately. Chest 1997; 111:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khirani S, Ramirez A, Aubertin G, et al. Respiratory muscle decline in Duchenne muscular dystrophy. Pediatr Pulmonol 2014; 49:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nève V, Edmé JL, Matran R. Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy. Eur Respir J 2014; 44:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uldry C, Janssens JP, de Muralt B, Fitting JW. Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyall RA, Donaldson N, Polkey MI, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124:2000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rafferty GF, Leech S, Knight L, et al. Sniff nasal inspiratory pressure in children. Pediatr Pulmonol 2000; 29:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller JM, Moxham J, Green M. The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond) 1985; 69:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harik-Khan RI, Wise RA, Fozard JL. Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998; 158:1459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carpenter MA, Tockman MS, Hutchinson RG, et al. Demographic and anthropometric correlates of maximum inspiratory pressure: The Atherosclerosis Risk in Communities Study. Am J Respir Crit Care Med 1999; 159:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larson JL, Covey MK, Vitalo CA, et al. Maximal inspiratory pressure. Learning effect and test-retest reliability in patients with chronic obstructive pulmonary disease. Chest 1993; 104:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fiz JA, Carreres A, Rosell A, et al. Measurement of maximal expiratory pressure: effect of holding the lips. Thorax 1992; 47:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koulouris N, Mulvey DA, Laroche CM, et al. Comparison of two different mouthpieces for the measurement of Pimax and Pemax in normal and weak subjects. Eur Respir J 1988; 1:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wohlgemuth M, van der Kooi EL, Hendriks JC, et al. Face mask spirometry and respiratory pressures in normal subjects. Eur Respir J 2003; 22:1001.
          </a>
         </li>
         <li class="breakAll">
          American Thoracic Society. Pulmonary Function Laboratory Management and Procedure Manual, Wanger J, Crapo RO, Irvin CG (Eds), 2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sclauser Pessoa IM, Franco Parreira V, Fregonezi GA, et al. Reference values for maximal inspiratory pressure: a systematic review. Can Respir J 2014; 21:43.
          </a>
         </li>
         <li class="breakAll">
          Moxham J. Lung function tests: Physiological principles and clinical applications. In: Respiratory Muscles, Hughes JB, Pride NB, Saunders WB (Eds), London 1999.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldrich TK, Spiro P. Maximal inspiratory pressure: does reproducibility indicate full effort? Thorax 1995; 50:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rochester DF. Tests of respiratory muscle function. Clin Chest Med 1988; 9:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orozco-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J Suppl 2003; 46:41s.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morrison NJ, Richardson J, Dunn L, Pardy RL. Respiratory muscle performance in normal elderly subjects and patients with COPD. Chest 1989; 95:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore AJ, Soler RS, Cetti EJ, et al. Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD. Respir Med 2010; 104:1319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polkey MI, Kyroussis D, Hamnegard CH, et al. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:1310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steier J, Kaul S, Seymour J, et al. The value of multiple tests of respiratory muscle strength. Thorax 2007; 62:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mier A. Respiratory muscle weakness. Respir Med 1990; 84:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson CE, Rosenfeld J, Moore DH, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 2001; 191:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laroche CM, Carroll N, Moxham J, Green M. Clinical significance of severe isolated diaphragm weakness. Am Rev Respir Dis 1988; 138:862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mier-Jedrzejowicz A, Brophy C, Moxham J, Green M. Assessment of diaphragm weakness. Am Rev Respir Dis 1988; 137:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax 1980; 35:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgan RK, McNally S, Alexander M, et al. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Man WD, Kyroussis D, Fleming TA, et al. Cough gastric pressure and maximum expiratory mouth pressure in humans. Am J Respir Crit Care Med 2003; 168:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szeinberg A, Tabachnik E, Rashed N, et al. Cough capacity in patients with muscular dystrophy. Chest 1988; 94:1232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Palen J, Rea TD, Manolio TA, et al. Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 2004; 59:1063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Celli BR. Clinical and physiologic evaluation of respiratory muscle function. Clin Chest Med 1989; 10:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polkey MI, Lyall RA, Yang K, et al. Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis. Am J Respir Crit Care Med 2017; 195:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maillard JO, Burdet L, van Melle G, Fitting JW. Reproducibility of twitch mouth pressure, sniff nasal inspiratory pressure, and maximal inspiratory pressure. Eur Respir J 1998; 11:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keenan SP, Alexander D, Road JD, et al. Ventilatory muscle strength and endurance in myasthenia gravis. Eur Respir J 1995; 8:1130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goswami R, Guleria R, Gupta AK, et al. Prevalence of diaphragmatic muscle weakness and dyspnoea in Graves' disease and their reversibility with carbimazole therapy. Eur J Endocrinol 2002; 147:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nava S, Crotti P, Gurrieri G, et al. Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction. Chest 1992; 101:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laroche CM, Mier AK, Moxham J, Green M. The value of sniff esophageal pressures in the assessment of global inspiratory muscle strength. Am Rev Respir Dis 1988; 138:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkinson NS, Dayer MJ, Moxham J, Polkey MI. Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease. Respir Res 2010; 11:15.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6965 Version 24.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12186831" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : ATS/ERS Statement on respiratory muscle testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30956204" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : ERS statement on respiratory muscle testing at rest and during exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8162993" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Portable measurement of maximum mouth pressures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A method for measuring sniff nasal inspiratory pressure using the PK Morgan Pm meter
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8306041" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19796415" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The assessment of maximal respiratory mouth pressures in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9118723" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : How many maneuvers are required to measure maximal inspiratory pressure accurately.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23836708" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Respiratory muscle decline in Duchenne muscular dystrophy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25142488" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Earlier decline in sniff nasal inspiratory pressure than peak expiratory flow in children with Duchenne muscular dystrophy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9192931" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11571218" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10821729" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Sniff nasal inspiratory pressure in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4064560" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The maximal sniff in the assessment of diaphragm function in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817693" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9927352" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Demographic and anthropometric correlates of maximum inspiratory pressure: The Atherosclerosis Risk in Communities Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8339633" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Maximal inspiratory pressure. Learning effect and test-retest reliability in patients with chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1465756" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Measurement of maximal expiratory pressure: effect of holding the lips.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3229485" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Comparison of two different mouthpieces for the measurement of Pimax and Pemax in normal and weak subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14680093" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Face mask spirometry and respiratory pressures in normal subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14680093" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Face mask spirometry and respiratory pressures in normal subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24137574" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Reference values for maximal inspiratory pressure: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24137574" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Reference values for maximal inspiratory pressure: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7886647" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Maximal inspiratory pressure: does reproducibility indicate full effort?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3292126" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Tests of respiratory muscle function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14621106" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2909360" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Respiratory muscle performance in normal elderly subjects and patients with COPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20399631" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8912741" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Diaphragm strength in chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17557772" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The value of multiple tests of respiratory muscle strength.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2247665" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Respiratory muscle weakness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11676995" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3202460" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Clinical significance of severe isolated diaphragm weakness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3354995" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Assessment of diaphragm weakness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7444828" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Analysis of lung volume restriction in patients with respiratory muscle weakness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15516537" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12857722" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Cough gastric pressure and maximum expiratory mouth pressure in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3191765" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Cough capacity in patients with muscular dystrophy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15563706" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Respiratory muscle strength and the risk of incident cardiovascular events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2661118" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Clinical and physiologic evaluation of respiratory muscle function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27494149" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2868172" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Statistical methods for assessing agreement between two methods of clinical measurement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9623695" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Reproducibility of twitch mouth pressure, sniff nasal inspiratory pressure, and maximal inspiratory pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7589397" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ventilatory muscle strength and endurance in myasthenia gravis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12213666" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Prevalence of diaphragmatic muscle weakness and dyspnoea in Graves' disease and their reversibility with carbimazole therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1345900" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3202414" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The value of sniff esophageal pressures in the assessment of global inspiratory muscle strength.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20132549" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
